122 related articles for article (PubMed ID: 3220460)
1. Growth-stimulating effects of somatomedin-/insulin-like peptides in Snell dwarf mice.
van Buul-Offers S; Hoogerbrugge CM; Branger J; Feijlbrief M; Van den Brande JL
Horm Res; 1988; 29(5-6):229-36. PubMed ID: 3220460
[TBL] [Abstract][Full Text] [Related]
2. Biosynthetic somatomedin C (SM-C/IGF-I) increases the length and weight of Snell dwarf mice.
van Buul-Offers S; Ueda I; Van den Brande JL
Pediatr Res; 1986 Sep; 20(9):825-7. PubMed ID: 3748655
[TBL] [Abstract][Full Text] [Related]
3. Recombinant insulin-like growth factor-II inhibits the growth-stimulating effect of growth hormone on the liver of Snell dwarf mice.
van Buul-Offers SC; Reijnen-Gresnigt MG; Hoogerbrugge CM; Bloemen RJ; Kuper CF; Van den Brande JL
Endocrinology; 1994 Sep; 135(3):977-85. PubMed ID: 7520865
[TBL] [Abstract][Full Text] [Related]
4. Biosynthetic human growth hormone: effects on growth of Snell dwarf mice.
van Buul-Offers S; Van den Brande JL
Horm Metab Res; 1985 Jan; 17(1):20-4. PubMed ID: 3967843
[TBL] [Abstract][Full Text] [Related]
5. Human insulin-like growth factor (IGF) binding protein-1 inhibits IGF-I-stimulated body growth but stimulates growth of the kidney in snell dwarf mice.
Van Buul-Offers SC; Van Kleffens M; Koster JG; Lindenbergh-Kortleve DJ; Gresnigt MG; Drop SL; Hoogerbrugge CM; Bloemen RJ; Koedam JA; Van Neck JW
Endocrinology; 2000 Apr; 141(4):1493-9. PubMed ID: 10746655
[TBL] [Abstract][Full Text] [Related]
6. Growth responses in a mutant dwarf rat to human growth hormone and recombinant human insulin-like growth factor I.
Skottner A; Clark RG; Fryklund L; Robinson IC
Endocrinology; 1989 May; 124(5):2519-26. PubMed ID: 2707163
[TBL] [Abstract][Full Text] [Related]
7. Isolation and partial characterization of six somatomedin-like peptides from human plasma Cohn fraction IV.
Blum WF; Ranke MB; Bierich JR
Acta Endocrinol (Copenh); 1986 Feb; 111(2):271-84. PubMed ID: 3953237
[TBL] [Abstract][Full Text] [Related]
8. Dexamethasone differentially inhibits thyroxine- or growth hormone-induced body and organ growth of Snell dwarf mice.
Rooman RP; Kuijpers G; Gresnigt R; Bloemen R; Koster JG; van Buul-Offers SC
Endocrinology; 2003 Jun; 144(6):2553-8. PubMed ID: 12746318
[TBL] [Abstract][Full Text] [Related]
9. Co-administration of IGF-binding protein-3 differentially inhibits the IGF-I-induced total body and organ growth of Snell dwarf mice.
van Buul-Offers S; Reijnen-Gresnigt R; Bloemen R; Hoogerbrugge C; Van den Brande JL
Prog Growth Factor Res; 1995; 6(2-4):377-83. PubMed ID: 8817681
[TBL] [Abstract][Full Text] [Related]
10. Growth hormone and insulin-like growth factor I treatment increase testicular luteinizing hormone receptors and steroidogenic responsiveness of growth hormone deficient dwarf mice.
Chatelain PG; Sanchez P; Saez JM
Endocrinology; 1991 Apr; 128(4):1857-62. PubMed ID: 2004605
[TBL] [Abstract][Full Text] [Related]
11. The Snell-dwarfmouse. II. Sulphate and thymidine incorporation in costal cartilage and somatomedin levels before and during growth hormone and thyroxine therapy.
van Buul S; Van den Brande JL
Acta Endocrinol (Copenh); 1978 Dec; 89(4):646-58. PubMed ID: 716773
[TBL] [Abstract][Full Text] [Related]
12. Growth hormone dependence of somatomedin-C/insulin-like growth factor-I and insulin-like growth factor-II messenger ribonucleic acids.
Hynes MA; Van Wyk JJ; Brooks PJ; D'Ercole AJ; Jansen M; Lund PK
Mol Endocrinol; 1987 Mar; 1(3):233-42. PubMed ID: 3453890
[TBL] [Abstract][Full Text] [Related]
13. Effect of bovine growth hormone and a partially pure preparation of somatomedin on various growth parameters in hypopituitary dwarf mice.
Holder AT; Spencer EM; Preece MA
J Endocrinol; 1981 May; 89(2):275-82. PubMed ID: 7241014
[TBL] [Abstract][Full Text] [Related]
14. Effects of growth hormone, prolactin and thyroxine on body wegith, somatomedin-like activity and in-vivo sulphation of cartilage in hypopituitary dwarf mice.
Holder AT; Wallis M; Biggs P; Preece MA
J Endocrinol; 1980 Apr; 85(1):35-41. PubMed ID: 7391723
[TBL] [Abstract][Full Text] [Related]
15. Insulin-like growth factor I stimulates growth in normal growing rats.
Hizuka N; Takano K; Shizume K; Asakawa K; Miyakawa M; Tanaka I; Horikawa R
Eur J Pharmacol; 1986 Jun; 125(1):143-6. PubMed ID: 3732389
[TBL] [Abstract][Full Text] [Related]
16. Effects of Spirometra erinacei plerocercoids on the growth of Snell dwarf mice.
Shiwaku K; Hirai K; Torii M; Tsuboi T
Parasitology; 1983 Dec; 87 (Pt 3)():447-53. PubMed ID: 6657302
[TBL] [Abstract][Full Text] [Related]
17. Effect of growth hormone and peptide fractions containing somatomedin activity on growth and cartilage metabolism of Snell dwarfmice.
Van den Brande JL; van Buul-Offers S
Acta Endocrinol (Copenh); 1979 Oct; 92(2):242-57. PubMed ID: 494990
[No Abstract] [Full Text] [Related]
18. Fetal rat myoblasts release both rat somatomedin-C (SM-C)/insulin-like growth factor I (IGF I) and multiplication-stimulating activity in vitro: partial characterization and biological activity of myoblast-derived SM-C/IGF I.
Hill DJ; Crace CJ; Nissley SP; Morrell D; Holder AT; Milner RD
Endocrinology; 1985 Nov; 117(5):2061-72. PubMed ID: 4042975
[TBL] [Abstract][Full Text] [Related]
19. Clinical use of somatomedin-1: yes or no?
Laron Z
Paediatr Drugs; 1999; 1(3):155-9. PubMed ID: 10937448
[TBL] [Abstract][Full Text] [Related]
20. Insulin-like growth factor characteristics of an acidic non-suppressible insulin-like activity.
Herington AC; Kuffer AD
Biochem J; 1984 Oct; 223(1):89-96. PubMed ID: 6388566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
